Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,001–1,100 of 2,099
Whytock, K. L., Parry, S. A., Turner, M. C., Woods, R. M., James, L. J., Ferguson, R. A., Ståhlman, M., Borén, J., Strauss, J. A., Cocks, M. S., et al. (2020) · The Journal of Physiology · doi:10.1113/jp279129 · Cited by 18
“Peripheral insulin resistance is a prominent feature of the type 2 diabetic phenotype (DeFronzo & Tripathy, 2009).”
BackgroundSalto, R., Girón, M. D., Manzano, M., Martín, M. J., Vílchez, J. D., Bueno-Vargas, P., Cabrera, E., Pérez-Alegre, M., Andújar, E., Rueda, R., et al. (2020) · Nutrients · doi:10.3390/nu12020528 · Cited by 16
“Low muscle glycogen content has been described as an early marker of insulin resistance [35].”
BackgroundSilva, T. D. O., Lino, C. A., Buzatto, V. C., Asprino, P. F., Lu, Y. W., Lima, V. M., Fonseca, R. I., Jensen, L., Murata, G. M., Filho, S. V., et al. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000309 · Cited by 14
Metabolic syndrome in children (Review)
Wu, Y., Zhang, C.-L., & Zhen, Q. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3632 · Cited by 20
“As previously discussed, insulin resistance in adipose tissue manifests itself as the inability to suppress lipolysis, which leads to an influx of FFAs to the liver, skeletal muscle and other organs leading to insulin resistance in these tissues (35).”
Kelly, B. M., Xenophontos, S., King, J. A., & Nimmo, M. A. (2017) · BMC Obesity · doi:10.1186/s40608-017-0151-7 · Cited by 18
“In overweight and obese individuals the core defect underlying the development of type 2 diabetes mellitus (T2DM) is skeletal muscle insulin resistance [1].”
BackgroundAli, A., Mashwani, Z., Ahmad, I., Raja, N. I., Mohammad, S., & Khan, S. U. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1029942 · Cited by 15
“The most critical organ behind the stomach is the pancreas, which produces insulin hormone that acts as a carrier and lets sugar into cells (18).”
BackgroundLee, M., Ryu, H., Van, J. Y., Kim, M., Jeong, H. H., Jung, W., Jun, J. Y., & Lee, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411467 · Cited by 14
“Insulin resistance is a key feature of T2D, and skeletal muscle is the primary site of insulin-stimulated glucose uptake.”
BackgroundInfluentialLi, Z., Tong, X., Ma, Y., Bao, T., & Yue, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077484 · Cited by 14
He, Y.-Y., Jin, M.-L., Fang, X., & Wang, X.-J. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02265-6 · Cited by 14
“These results were consistent with previous literature reports that skeletal muscle dysregulation is associated with insulin resistance and skeletal muscle insulin resistance has been known to be the primary defect in T2DM [5, 7].”
Li, X., Yang, J., Hu, W., Ruan, Y., Chen, H. Y., Zhang, Q., Zhang, Z., & Ding, Z. S. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13540 · Cited by 13
“5,6 Mitochondria-associated membranes (MAMs) are dynamic domains facilitating communication between mitochondria and endoplasmic reticulum (ER).”
BackgroundPassaro, A., Sanz, J. M., Naumovski, N., & Sergi, D. (2024) · Advances in Redox Research · doi:10.1016/j.arres.2024.100100 · Cited by 19
Vieira‐Lara, M. A., & Bakker, B. M. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167172 · Cited by 20
Akar, E. A., Weill, L., Khoury, M. E., Caradeuc, C., Bertho, G., Boutary, S., Bézier, C., Clerc, Z., Sapaly, D., Bendris, S., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00850-7 · Cited by 12
“An important aspect still relatively unexplored in T2DM that could greatly influence patient response to exercise is the muscle metabolic status which could vary depending on the individual pathological patterns (Maier and Gould 2000; DeFronzo and Tripathy 2009; Tumova et al. 2016).”
BackgroundWang, L., Guo, D., Huang, Y., Long, P., Zhang, X., Bai, L., Liu, J., Hu, X., Pang, R., & Gou, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1472413 · Cited by 20
Extensive differential gene expression and regulation by sex in human skeletal muscle
Hanks, S. C., Mauger, A. S., Varshney, A., Ciotlos, D. L., Manickam, N., Narisu, N., Shumway, A. J., Orchard, P., Erdos, M. R., Sweeney, M. D., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100915 · Cited by 16
Navarro-Márquez, M., Torrealba, N., Troncoso, R., Vásquez-Trincado, C., Rodriguez, M., Morales, P. E., Villalobos, E., Eura, Y., García, L., Chiong, M., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.02.018 · Cited by 16
Novel metabolic disorders in skeletal muscle of Lipodystrophic Bscl2/Seipin deficient mice
Xu, W., Zhou, H., Xuan, H., Saha, P. K., Wang, G., & Chen, W. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.001 · Cited by 14
“Impaired glycogen synthesis and accumulation of intramyocellular triglyceride (IMTG) have been implicated in the pathogenesis of muscle insulin resistance (DeFronzo and Tripathy, 2009; Dohm et al., 1988).”
BackgroundBarclay, R. D., Beals, J. W., Drnevich, J. M., Imai, B. S., Yau, P. M., ULANOV, A. V., Tillin, N. A., Villegas-Montes, M., Paluska, S. A., Watt, P., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153996 · Cited by 13
Amorim, N. M. L., Kee, A. J., Coster, A. C. F., Lucas, C. A., Bould, S., Daniel, S., Weir, J. M., Mellett, N. A., Barbour, J. A., Meikle, P. J., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154025 · Cited by 15
Teofilović, A., Brkljačić, J. M., Djordjevic, A. D., Milutinović, D. V., Tappy, L., Matić, G. M., & Veličković, N. A. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1728236 · Cited by 13
Falsehoods and facts about dietary sugars: a call for evidence-based policy
Archer, E., & Arjmandi, B. H. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1804320 · Cited by 14
Simaitis, S., Schulte-Körne, B., Schiffer, T., Bloch, W., Predel, H., Brixius, K., & Brinkmann, C. K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.599651 · Cited by 14
“Skeletal muscle is the pre-dominant site of prostprandial insulin-mediated glucose uptake and is therefore of high metabolic importance (DeFronzo and Tripathy, 2009).”
BackgroundLeCroy, M. N., Hua, S., Kaplan, R. C., Sotres‐Alvarez, D., Qi, Q., Thyagarajan, B., Gallo, L. C., Pirzada, A., Daviglus, M. L., Schneiderman, N., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108557 · Cited by 16
“For example, in a euglycemic hyperinsulinemia state, skeletal muscle accounts for approximately 80% of postprandial glucose uptake (7,8) and non-oxidative glucose storage (i.”
BackgroundSonsalla, M. M., Love, S. L., Hoh, L. J., Summers, L. N., Follett, H. M., Bojang, A., Duddleston, K. N., & Kurtz, C. C. (2021) · Journal of Comparative Physiology B · doi:10.1007/s00360-021-01384-8 · Cited by 16
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Genes & Nutrition · doi:10.1186/s12263-021-00695-3 · Cited by 17
Mst1/2 Is Necessary for Satellite Cell Differentiation to Promote Muscle Regeneration
Yang, J., Wang, K., An, Y., Wu, R., Li, J., Wang, H., & Dong, Y. (2021) · Stem Cells · doi:10.1093/stmcls/sxab010 · Cited by 13
Vanderboom, P. M., Zhang, X., Hart, C. R., Kunz, H., Gries, K. J., Heppelmann, C. J. H., Liu, Y., Dasari, S., & Lanza, I. R. (2022) · Obesity · doi:10.1002/oby.23419 · Cited by 12
“Skeletal muscle from individuals with obesity exhibits phenotypic traits, including mitochondrial impairments (2), oxidative stress (3), and insulin resistance (4) that contribute to comorbidities (5).”
BackgroundCheng, J., Xu, L., Yu, Q., Lin, G., Ma, X., Li, M., Guan, F., Liu, Y., Huang, X., Xie, J., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175234 · Cited by 14
Park, J.-E., & Han, J.-S. (2022) · Nutrients · doi:10.3390/nu14183815 · Cited by 16
Mazzoli, A., Porzio, A. D., Gatto, C., Crescenzo, R., Nazzaro, M., Spagnuolo, M. S., Baccigalupi, L., Ricca, E., Amoresano, A., Fontanarosa, C., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109247 · Cited by 14
Tammineni, E. R., Figueroa, L., Manno, C. D., Varma, D., Kraeva, N., Ibarra, C. A., Klip, A., Riazi, S., & Ríos, E. (2023) · eLife · doi:10.7554/elife.78874 · Cited by 16
“…of GSK3 β found in these patients constitutes an additional link in the pathogenic chain that leads from increased [Ca 2+ ] cyto to alteration in muscle utilization of glucose, then to hyperglycemia and diabetes ( Tammineni et al., 2020 ; Altamirano et al., 2019 ; DeFronzo and Tripathy, 2009 ).”
Jevtovic, F., Lopez, C. A., Zheng, D., Cortright, R. N., Biagioni, E. M., Claiborne, A., Isler, C. M., DeVente, J., Houmard, J. A., May, L. E., et al. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00737.2022 · Cited by 14
Design of a Truncated Cardiotoxin-I Analogue with Potent Insulinotropic Activity
Nguyen, T. T. N., Folch, B., Létourneau, M., Truong, N. H., Doucet, N., Fournier, A., & Chatenet, D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401904q · Cited by 14
Ghosh, D., Peng, J., Sirsi, S. R., Mineo, C., Mattrey, R. F., Shaul, P. W., & Hoyt, K. (2017) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2017.8092192 · Cited by 13
“A major aspect of type 2 diabetes and obesity-induced insulin resistance is impaired insulin action in the skeletal muscle, where greater than 80% of whole body glucose disposal normally occurs [1].”
BackgroundZhang, N., Zhou, Y., Yuan, Q., Gao, Y., Wang, Y., Wang, X., Cui, X., Xu, P., Ji, C., Guo, X., et al. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.08.013 · Cited by 14
Premilovac, D., Attrill, E., Rattigan, S., Richards, S. M., Kim, J., & Keske, M. A. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy225 · Cited by 15
R3hdml regulates satellite cell proliferation and differentiation
Sakamoto, K., Furuichi, Y., Yamamoto, M., Takahashi, M., Akimoto, Y., Ishikawa, T., Shimizu, T., Fujimoto, M., Takada‐Watanabe, A., Hayashi, A., et al. (2019) · EMBO Reports · doi:10.15252/embr.201947957 · Cited by 14
“Skeletal muscles also function as the largest metabolic organ in the body, consuming the majority of blood glucose [2].”
BackgroundThe effect of cold exposure with shivering on glucose tolerance in healthy men
Sellers, A. J., Pallubinsky, H., Rense, P., Bijnens, W., van de Weijer, T., Moonen‐Kornips, E., Schrauwen, P., & Lichtenbelt, W. D. V. M. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00642.2020 · Cited by 16
Key Metabolic Functions of β-Arrestins: Studies with Novel Mouse Models
Pydi, S. P., Barella, L. F., Meister, J., & Wess, J. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.11.008 · Cited by 15
The physiology of interoception and its adaptive role in consciousness
Singer, J., & Damásio, A. R. (2025) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0305 · Cited by 23
Impact of muscle mass on blood glucose level
Taha, M., Alnaam, Y., Al-Maqati, T. N., Musallam, L. A., Altalib, G., Alowfi, D., & Haider, N. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0316 · Cited by 17
Enterocyte HKDC1 Modulates Intestinal Glucose Absorption in Male Mice Fed a High-fat Diet
Zapater, J. L., Wicksteed, B. L., & Layden, B. T. (2022) · Endocrinology · doi:10.1210/endocr/bqac050 · Cited by 11
“Next, we examined whether alteration in glucose uptake by skeletal muscle, which accounts for 80% to 90% of glucose uptake in the postprandial state (37, 38) could result in the enhanced glucose excursion seen in HFD-fed HKDC1Int–/– mice.”
BackgroundCharacterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
McDonnell, T., Cussen, L., McIlroy, M., & O’Reilly, M. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221113140 · Cited by 18
Kasongo, A. A., Leroux, M., Amrouche-Mekkioui, I., Belhadji-Domecq, M., & Aguer, C. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113505 · Cited by 13
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism
Molinari, S., Imbriano, C., Moresi, V., Renzini, A., Belluti, S., Lozanoska‐Ochser, B., Gigli, G., & Cedola, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1130183 · Cited by 13
“Of note, genetic polymorphisms on Sirt1 and Sirt2 genes have been associated with T2D development and insulin resistance (Maeda et al., 2011; Liu et al., 2018).”
BackgroundInfluentialHayashi, T., Wada, N., Kubota, T., Koizumi, C., Sakurai, Y., Aihara, M., Usami, S., Yamauchi, T., & Kubota, N. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14007 · Cited by 14
Li, Q., Jiang, X., Zhou, Y., Gu, Y., Ding, Y., Luo, J., Pang, N., Sun, Y., Pei, L., Pan, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210015 · Cited by 15
“Thus, IR in skeletal muscle takes a major responsibility for hyperglycemia [4].”
BackgroundGreyslak, K. T., Hetrick, B., Bergman, B. C., Dean, T. A., Wesolowski, S. R., GANNON, M. A., Schenk, S., Sullivan, E. L., Aagaard, K. M., Kievit, P., et al. (2023) · Diabetes · doi:10.2337/db23-0289 · Cited by 11
Zanner, S., Goff, E., Ghatan, S., Wölfel, E. M., Ejersted, C., Kuhn, G. A., Müller, R., & Frost, M. (2023) · JBMR Plus · doi:10.1002/jbm4.10832 · Cited by 12
Xu, P., Kong, Y., Palmer, N. D., Ng, M. C. Y., Zhang, B., & Das, S. K. (2024) · Aging Cell · doi:10.1111/acel.14199 · Cited by 14
“…the two major organs responsible for nutrient availability and energy metabolism: Adipose tissue plays a crucial role in storing lipids for energy homeostasis, whereas skeletal muscle accounts for approximately 80% of postprandial glucose disposal (DeFronzo & Tripathy, 2009; Kershaw & Flier, 2004).”
BackgroundA multi‐omics approach to overeating and inactivity‐induced muscle atrophy in db/db mice
Okamura, T., Hamaguchi, M., Kobayashi, G., Ichikawa, T., Hasegawa, Y., Miyoshi, T., Senmaru, T., Nakanishi, N., Sasano, R., & Fukui, M. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13550 · Cited by 12
“21 Correlation analysis between metabolites and genes indicated a negative association be-tween saturated fatty acids and Myh1, 2, and 4 expressions, suggesting their role in obesity related inactivity-induced muscle atrophy.”
BackgroundCalcaterra, V., Magenes, V. C., Bianchi, A., Rossi, V., Gatti, A., Marin, L., Vandoni, M., & Zuccotti, G. (2024) · Life · doi:10.3390/life14091198 · Cited by 23
“Skeletal muscle accounts for more than 80% of glucose absorption in the post-meal state [73], playing a vital role in regulating blood glucose levels.”
BackgroundInfluentialLambert, G. W., Patel, M., & Lambert, É. (2025) · Metabolites · doi:10.3390/metabo15050286 · Cited by 15
“Previous studies have clearly demonstrated that the sympathetic nervous system has anabolic effects on skeletal muscle [215] and that skeletal muscle is responsible for the majority of glucose uptake following an oral glucose load [216].”
Hamari, N., Blaak, E. E., & Canfora, E. E. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1603490 · Cited by 15
Fiorentino, T. V., Succurro, E., Arturi, F., Giancotti, A., Peronace, C., Quirino, A., Sesti, F. F., Andreozzi, F., Hribal, M. L., Perticone, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32108-8 · Cited by 13
Joseph, S., Alava, B. R., Antolic, A. T., Richards, E. M., Wood, C. E., & KELLER-WOOD, M. E. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00096.2019 · Cited by 15
“Though not necessary for viability in the immediate postnatal period, the biceps femoris and other skeletal muscles are important metabolic organs, accounting for 80% of peripheral glucose utilization (16).”
BackgroundNúñez, J. E. M., Zamilpa, A., Fortis-Barrera, Á., Alarcón-Aguilar, F. J., Loza‐Rodriguez, H., Gómez-Quiroz, L. E., Salas‐Silva, S., Flores-Cruz, M., Zavala-Sánchez, M. Á., & Blancas‐Flores, G. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153622 · Cited by 13
Luong, T. V., Pedersen, M. G. B., Kjærulff, M. L. G., Madsen, S., Lauritsen, K. M., Tolbod, L. P., Søndergaard, E., & Gormsen, L. C. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154862 · Cited by 12
Devarshi, P. P., Pereyra, A. S., Ellis, J. M., & Henagan, T. M. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14541 · Cited by 12
“tissues to exhibit insulin resistance in overweight and obese individuals.(37,38) Additionally, in subjects with impaired glucose tolerance and type 2 diabetes, exercise increases insulin sensitivity.”
BackgroundIn vivo metabolic effects after acute activation of skeletal muscle Gs signaling
Meister, J., Bone, D. B. J., Knudsen, J. R., Barella, L. F., Liu, L., Lee, R., Gavrilova, O., Chen, M., Weinstein, L. S., Kleinert, M., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101415 · Cited by 13
Gu, L., Wang, Z., Zhang, Y., Zhu, N., Li, J., Yang, M. G., Wang, X., & Rong, S. (2022) · Cell Proliferation · doi:10.1111/cpr.13181 · Cited by 13
Photobiomodulation Therapy on the Treatment of Insulin Resistance: A Narrative Review
Magalhães, F. D. C., & Ferraresi, C. (2022) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2022.0031 · Cited by 17
Uses of Papaya Leaf and Seaweed Supplementations for Controlling Glucose Homeostasis in Diabetes
Nyakundi, B. B., & Yang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076846 · Cited by 22
“Furthermore, the activated AKT (Gag AKT) induces glycogen synthesis by stimulating glycogen synthase (GS) in the skeletal muscles, which redirects glucose-6-phosphate’s fate and inhibits glycogen synthase kinase-3 (GSK-3), as demonstrated in the L6 myotubes [27,28].”
BackgroundNo Acute Effect of Reduced-exertion High-intensity Interval Training (REHIT) on Insulin Sensitivity
Metcalfe, R. S., Fawkner, S. G., & Vollaard, N. B. J. (2016) · International Journal of Sports Medicine · doi:10.1055/s-0035-1564258 · Cited by 14
“Insulin sensitivity is an important biomarker in the development of type 2 diabetes and 34 metabolic syndrome and is a primary target for preventative intervention [8,33].”
BackgroundThaane, T., Motala, A. A., & McKune, A. J. (2019) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2019.1608054 · Cited by 16
Black, A. J., Ravi, S., Jefferson, L. S., Kimball, S. R., & Schilder, R. J. (2017) · Journal of Nutrition · doi:10.3945/jn.117.254482 · Cited by 12
Skeletal muscle in the fight against chronic diseases
Mrowka, R., & Westphal, A. (2018) · Acta Physiologica · doi:10.1111/apha.13086 · Cited by 13
“A reduced response of skeletal muscle tissue to insulin, called insulin resistance, is likely the primary defect leading to development of type 2 diabetes.(4,13) In a second step, progressive b-cell failure occurs and type 2 diabetes develops.”
BackgroundLopreiato, V., Hosseini, A., da Rosa, F. T., Zhou, Z., Alharthi, A. S., Trevisi, E., & Loor, J. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14389 · Cited by 15
“This type of discrepancy could be related to the fact that skeletal muscle is the most important user of glucose; that is, the glucose tolerance test data reflect peripheral utilization of glucose primarily by muscle (DeFronzo and Tripathy, 2009).”
BackgroundBakshi, I., Brown, S. H. J., Brandon, A. E., Suryana, E., Mitchell, T. W., Turner, N. A., & Cooney, G. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32354-w · Cited by 15
The Mechanisms of Insulin Action
White, M. F., & Copps, K. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00033-0 · Cited by 13
Management of bone and metabolic effects of androgen deprivation therapy
Russell, N., & Grossmann, M. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.10.007 · Cited by 15
Nylén, C., Lundell, L. S., Massart, J., Zierath, J. R., & Näslund, E. B. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00253.2018 · Cited by 12
“Therefore, changes in HOMA-IR reflect improvements in hepatic, rather than skeletal muscle, insulin sensitivity (10).”
BackgroundRosales-Nieto, C. A., Ferguson, M. B., Briegel, J. R., Hedger, M. P., Martin, G. B., & Thompson, A. N. (2019) · Reproduction in Domestic Animals · doi:10.1111/rda.13568 · Cited by 15
Demir, İ., Akan, O. Y., Güler, A., Bozkaya, G., Aslanıpour, B., & Çalan, M. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.10.003 · Cited by 15
Rehunen, S., Kautiainen, H., Korhonen, P. E., & Eriksson, J. G. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.003 · Cited by 12
Zeng, Q., Zou, D., Zeng, Q., Chen, X., Wei, Y., & Guo, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.774489 · Cited by 12
“Substantial evidence suggests that insulin resistance, an inherited genetic defect, is the basis and major feature of T2DM (DeFronzo and Tripathy, 2009; Cai et al., 2019; Li et al., 2021).”
BackgroundTran, D., Myers, S., McGowan, C. J., Henstridge, D. C., Eri, R. D., Sonda, S., & Caruso, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.772925 · Cited by 12
“1-DSA Impair Insulin-Stimulated Glucose Uptake in C2C12 Myotubes Glucose intolerance is a characteristic feature of T2DM, where insulin-responsive tissues like skeletal muscle lose their ability to be stimulated by insulin and uptake glucose, leading to compromised glucose homeostasis (10, 41).”
BackgroundPathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., John‐Kalarickal, J., & Fonseca, V. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_13 · Cited by 15
Göbl, C. S., Bozkurt, L., Mittlböck, M., Leutner, M., Yarragudi, R., Tura, A., Pacini, G., & Kautzky‐Willer, A. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00059.2015 · Cited by 13
Yan, P., Zhang, L., Feng, Y., Qu, H. Y., Qin, L., Zhang, L., & Leng, Y. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.196 · Cited by 13
Jung, M., Rieder, H., Reisert, M., Rospleszcz, S., Nattenmüller, J., Peters, A., Schlett, C. L., Bamberg, F., & Weiß, J. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13527 · Cited by 12
“27 In addition, it plays a key role in maintaining glucose homeostasis and insulin resistance.”
BackgroundYang, M., Sun, L., Feng, X., & Xu, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145706 · Cited by 22
Alves, A., Lamarche, F., Lefebvre, R., Mulard, E. D., Bassot, A., Chanon, S., Loizon, E., Pinteur, C., Bloise, A. M. N. D. L. G., Godet, M., et al. (2022) · Nutrients · doi:10.3390/nu15010096 · Cited by 15
“We further phenotyped the gastrocnemius muscle status since skeletal muscles are key tissues involved in glycine [26] and glucose [27] homeostasis.”
BackgroundMethodSingdam, P., Naowaboot, J., Senggunprai, L., Boonloh, K., Hipkaeo, W., & Pannangpetch, P. (2023) · Trends in Sciences · doi:10.48048/tis.2023.6455 · Cited by 12
Janssen, L., Hopman, M. T. E., Swaans, G. J. A., Allard, N. A. E., Boss, M., Lobeek, D., Gotthardt, M., Schirris, T. J. J., Blijlevens, N. M. A., & Timmers, S. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00163.2022 · Cited by 12
Eriobotrya japonica (Thunb.) Lindl leaves: Reviewing their specialized metabolites and pharmacology
Yao, Z., Cheng, F., Ming, T., Sun, C., Ran, Q., Zhang, C., Shen, C., Zhang, R., & Peng, C. (2023) · Biochemical Systematics and Ecology · doi:10.1016/j.bse.2023.104707 · Cited by 13
Liu, Y., Zhang, J., An, C., Liu, C., Zhang, Q., Ding, H., Ma, S., & Xue, W.-J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914828 · Cited by 12
Memelink, R. G., Njemini, R., Kuil, M. J. J. D. B., Wopereis, S., den Bosch, J. D. V., Schoufour, J. D., Tieland, M., Weijs, P. J. M., & Bautmans, I. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112410 · Cited by 15
“This is particularly important in type 2 diabetes because skeletal muscle is the predominant site of insulin-mediated glucose uptake in the postprandial state (DeFronzo and Tripathy, 2009).”
Hénin, G., Loumaye, A., Deldicque, L., Leclercq, I. A., & Lanthier, N. (2024) · Liver International · doi:10.1111/liv.15938 · Cited by 12
“67 One key mechanism of muscle glucose uptake is the membrane expression of glucose transporter 4 (GLUT4).”
Deli, C. K., Fatouros, I. G., Poulios, A., Liakou, C. A., Draganidis, D., Παπανικολάου, Κ., Rosvoglou, A., Gatsas, A., Georgakouli, K., Tsimeas, P. D., et al. (2024) · Life · doi:10.3390/life14081016 · Cited by 17
“Notably, skeletal muscle is responsible for most insulin-stimulated glucose uptake and postprandial storage [12] and accounts for nearly ~90% of the whole-body glucose metabolism [13].”
BackgroundKLF3 impacts insulin sensitivity and glucose uptake in skeletal muscle
Fu, S., Gong, X., Liang, K., Ding, K., Qiu, L., Cen, H., & Du, H. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00085.2024 · Cited by 13
Guo, C., He, L., Tu, Y., Xu, C., Liao, C., Lai, H., Lin, C., & Tu, H. (2024) · BMC Public Health · doi:10.1186/s12889-024-20214-4 · Cited by 10
“Skeletal muscle is the primary site of insulin-mediated glucose uptake in the postprandial state [48], and IR will result in abnormal muscle glucose metabolism, which in turn will lead to sarcopenia.”
BackgroundDou, C., Liu, D., Kong, L., Chen, M., Ye, C., Zhu, Z., Zheng, J., Xu, M., Xu, Y., Li, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156112 · Cited by 18
Dipeptidyl Peptidase-4 Inhibitors and Their Effects on the Cardiovascular System
Solun, B., Marcoviciu, D., & Dicker, D. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0382-2 · Cited by 13
ABCA1 genetic polymorphisms and type 2 diabetes mellitus and its complications
Haerian, B. S., Haerian, M. S., Roohi, A., & Mehrad‐Majd, H. (2017) · Meta Gene · doi:10.1016/j.mgene.2017.05.007 · Cited by 16
Secreted MG53 From Striated Muscle Impairs Systemic Insulin Sensitivity
Zhuang, L., Bassel‐Duby, R., & Olson, E. N. (2019) · Circulation · doi:10.1161/circulationaha.118.038387 · Cited by 11
Plant Neoflavonoids: Chemical Structures and Biological Functions
Kumar, P., Ahamad, T., Mishra, D. P., & Khan, M. F. (2020) · Springer eBooks · doi:10.1007/978-981-15-2361-8_3 · Cited by 13
Choe, H., Sung, H., Kim, G., Lee, O., Moon, H. Y., & Kim, Y. S. (2021) · Epidemiology and Health · doi:10.4178/epih.e2021080 · Cited by 13
“In general terms, by inhibiting the binding of insulin with its receptor, insulin resistance impairs glycogen synthesis by suppressing insulin’s stimulation of the glucose transport system in the muscles and inhibits the protein synthesis pathway, which is responsible for muscle hypertrophy [41,42].”
BackgroundRelationship between creatinine to body weight ratios and diabetes mellitus: A Chinese cohort study
Chen, Z., Zou, Y., Yang, F., Ding, X. H., Cao, C., Hu, H., & Wang, X. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13248 · Cited by 10
“It is one of the main parts of insulin-mediated glucose uptake, especially postprandial glucose.(36) Accompanied by decreased skeletal muscle mass, decreased insulin sensitivity, abnormal glucose, and fatty acid metabolism, the maintenance and increase of skeletal muscle mass may ameliorate insulin resistance.”
BackgroundGrundy, S. M. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_3 · Cited by 17
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.